NEW SURVEY NOW AVAILABLE

TAKE NEW SURVEY

NEW SURVEY NOW AVAILABLE

close
The UF Perspectives Survey Results Now Available | Global UF Perspectives

THE UF
PERSPECTIVES
SURVEY RESULTS
NOW AVAILABLE

Introduction Questions Results

Keeping the UF conversation alive

doctor ipad

The survey is still open so if you haven’t been part of this important conversation, visit ufperspectives.com – because your perspective is important too

1. Evidation Study. Survey of Americans who had Evidation’s mobile App installed, 92% female respondents
(82% premenopausal); Data on file, Myovant Sciences Ltd.
Do you feel that for many women there are feelings of stigma and taboo that prevents them talking about issues of female health such as uterine fibroids?

1. Do you feel that for many women there are feelings of stigma and taboo that prevents them talking about issues of female health such as uterine fibroids?

What are TWO most common symptoms of uterine fibroids that you encounter?

2. What are TWO most common symptoms of uterine fibroids that you encounter?

What is the overall impact of uterine fibroid symptoms on a typical patient’s life?

3. What is the overall impact of uterine fibroid symptoms on a typical patient’s life?

In your opinion, is surgery the only long-term treatment option for symptomatic uterine fibroids?

4. In your opinion, is surgery the only long-term treatment option for symptomatic uterine fibroids?

In women under 50 undergoing hysterectomy, what do you estimate to be the associated increase risk of Cardiovascular Disease (CVD) in later life?

5. In women under 50 undergoing hysterectomy, what do you estimate to be the associated increase risk of Cardiovascular Disease (CVD) in later life?

At 8 years post procedure, what recurrence rates would you estimate with laparoscopic and open myomectomy?

6. At 8 years post procedure, what recurrence rates would you estimate with laparoscopic and open myomectomy?

Which of the following medical treatments have you used for uterine fibroids?

7. Which of the following medical treatments have you used for uterine fibroids?

Are you aware of a potential new class of treatments for uterine fibroids?

8. Are you aware of a potential new class of treatments for uterine fibroids?

Assuming safety was not an issue, what MINIMUM long-term efficacy* would a medical treatment need to demonstrate before you would prescribe it for symptomatic uterine fibroids?

9. Assuming safety was not an issue, what MINIMUM long-term efficacy* would a medical treatment need to demonstrate before you would prescribe it for symptomatic uterine fibroids?

If significant clinical outcomes were visible by the first menstruation following the start of treatment, would this be acceptable?

10. If significant clinical outcomes were visible by the first menstruation following the start of treatment, would this be acceptable?

The survey is still open so if you haven’t been part of this important conversation, visit ufperspectives.com - because your perspective is important too

More than half of HCPs think women feel stigma that prevents them talking about UF

Do you feel that for many women there are feelings of stigma and taboo that prevents them talking about issues of female health such as uterine fibroids?Do you feel that for many women there are feelings of stigma and taboo that prevents them talking about issues of female health such as uterine fibroids?

Q1 pie

Q1 graph

Q1 data what do women say 1. Evidation Study. Survey of Americans who had Evidation’s mobile App installed, 92% female respondents
(82% premenopausal); Data on file, Myovant Sciences Ltd.

X

5,000 Euphemisms exist globally for the word PERIOD1

  • Perhaps this typifies the stigma and taboo many women still feel about discussing some aspects of female health
  • A large study across all US states in >13,000 people assessed menstrual experiences, symptoms and attitudes2
    • 68% of all respondents agree there is a stigma around menstruation in society today2
    • 60% agree that menstruation is embarrassing to talk about2
    • 40% said they do not feel they have had adequate education around menstruation2
  • This study also showed that many women suffer with heavy menstrual bleeding and pain – typical symptoms of uterine fibroids2*
    • 83% of women experienced heavy menstrual bleeding2
    • But only 37% consulted their healthcare professional2 – 96% experienced pain2
    • But only 46% consulted their healthcare professional2

Could these feelings of stigma and taboo mean that women are less likely to talk to their HCP about symptoms that could potentially be uterine fibroids?

* These women were not formally diagnosed with uterine fibroids
1 https://helloclue.com/articles/culture/top-euphemisms-for-period-by-language
2 Evidation Study. Survey of Americans who had Evidation’s mobile App installed,
92% female respondents (82% premenopausal); Data on file, Myovant Sciences Ltd.

Heavy bleeding and pain are the two most common symptoms HCPs encounter

What are TWO most common symptoms of uterine fibroids that you encounter?What are TWO most common symptoms of uterine fibroids that you encounter?

Q2 graph Q2 data what are symptoms

X

Heavy menstrual bleeding and pain are common, direct symptoms of uterine fibroids1

  • Uterine fibroids affect millions of women worldwide2
  • 70-80% of women are affected by menopausal age3
  • Uterine fibroids are considered a public health concern in some countries like the USA4
  • Uterine fibroids can present with a number of different symptoms that in addition to heavy menstrual bleeding and pain, include: anaemia, pelvic pressure, abdominal distention, bowel or bladder dysfunction, infertility5

doctors

1 Al-Hendy A et al. Semin Reprod Med 2017;35:473–480.
2 Borah BJ et al. Am J Obstet Gynecol. 2013 October; 209(4): 319.e1–319.e20.
3 Baird DD et al. Am J Obstet Gynecol. 2003 Jan; 188(1):100-7.
4 Marsh EE et al. Semin Reprod Med 2017; 35:560-564.
5 Donnez J & Dolmans MM. Hum Reprod Update 2016; 22(6): 665=686.

Most HCPs felt that UF had a moderate impact on a woman’s life

What is the overall impact of uterine fibroid symptoms on a typical patient’s life?What is the overall impact of uterine fibroid symptoms on a typical patient’s life?

Q3 pie

  • Generally, male HCPs thought the impact of UF was greater than female HCPs

Q3 graph

Q3 as well what do women say 1. Ghant MS et al. J Womens Health 2016;25:846–852.
2. Ghant MS et al. J Psychosom Res 2015;78:499–503.

X

As well as the physical pain, uterine fibroids can also have a significant psychological impact on a woman’s life1,3

“…my period lasted for 30 days and it was heavy and it was horrible. I was wearing pads like the size that you get in the hospital after you have a baby and I was so used to that happening at that time… I didn’t call anybody because you know it was like this is normal.” 1 – Patient

percentage graph

“…this is what you go through as a woman… and it was like every month you are going to bleed half to death and then the rest of the time you are almost okay. I just went with that… you know it didn’t kill me so I would just be stronger.”2 – Patient

1 Ghant MS et al. J Womens Health 2016;25:846–852.
2 Ghant MS et al. J Psychosom Res 2015;78:499–503.
* In a survey of 60 symptomatic women

Most HCPs agree that surgery should not be the only long-term treatment option

In your opinion, is surgery the only long-term treatment option for symptomatic uterine fibroids?In your opinion, is surgery the only long-term treatment option for symptomatic uterine fibroids?

Q4 pie

The survey is still open so if you haven’t been part of this important conversation, visit ufperspectives.com – because your perspective is important too
Q4 surgery 1 Donnez J & Dolmans MM. Hum Reprod Update 2016; 22:665–686.
2 ACOG Practice Bulletin. No. 96. Obstet Gynecol 2008; 112: 387-400.

X

Surgery is NOT the only answer1,2

  • Although surgery is essential in some cases, it is not suitable for all women1
  • There are short- and long-term risks associated with hysterectomy and myomectomy1
  • It is likely that reducing the number of hysterectomies and other surgical procedures will reduce costs and morbidity in the management of UF1
  • Guidelines from the American College of Obstetricians and Gynecologists support women pursuing alternatives to hysterectomy irrespective of their gestational intention2

There is a recognised need for alternatives to surgical intervention in the management of UF1,2

1 Donnez J & Dolmans MM. Hum Reprod Update 2016; 22:665–686.
2 ACOG Practice Bulletin. No. 96. Obstet Gynecol 2008; 112: 387-400.

Most HCPs underestimated the cardiovascular disease (CVD) risk following hysterectomy in women under 50

In women under 50 undergoing hysterectomy, what do you estimate to be the associated increase risk of Cardiovascular Disease (CVD) in later life?In women under 50 undergoing hysterectomy, what do you estimate to be the associated increase risk of Cardiovascular Disease (CVD) in later life?

Q5 pie

Q5 in younger

X
  • A nationwide cohort study* in >800,000 Swedish women, evaluated the risk of CVD following a hysterectomy for benign indications1
  • In women under 50 also undergoing oophorectomy, the risk increases to 40%1

doctors

* Observational period: 1973-2003; hysterectomy n=184, 441 and non-hysterectomised controls n=640, 043. Main outcome was first hospitalisation or death from CVD (coronary heart disease, stroke or heart failure). The risk estimates were adjusted for socioeconomic status
1 Ingelsson E et al. Eur Heart J 2011; 32(6) :745-750.

Most HCPs significantly underestimate the recurrence rates associated with laparoscopic and open myomectomy

At 8 years post procedure, what recurrence rates would you estimate with laparoscopic and open myomectomy?At 8 years post procedure, what recurrence rates would you estimate with laparoscopic and open myomectomy?

Q6 pie


 

The survey is still open so if you haven’t been part of this important conversation, visit ufperspectives.com – because your perspective is important too
Q6 reintervention 1 Davis MR et al. J Wom Health 2018; 27(10). Published online: https://doi.org/10.1089/jwh.2017.6752
2 Kotani Y et al. J Obstet Gynaecol Res 2018; 44(2): 298-302.

X

Myomectomy does not always provide a definitive solution1,2

  • Reintervention rates after myomectomy:1,2*
    • 76.2% for laparoscopic myomectomy
    • 63.4% for abdominal myomectomy
  • Since the FDA warning in 2014 to utilise safer morcellation methods3, there has been a trend toward an increase in abdominal myomectomy3
    • Abdominal myomectomy is associated with a 3X HIGHER composite morbidity
      (16%) vs laparoscopic myomectomy (5%)4

* A total of 474 women underwent laparoscopic myomectomy (L-M) and 279 underwent open myomectomy (O-M).
The patients were followed up from 6 months to 8 years. Recurrence was confirmed when a myoma with a diameter of >1 was detected. Post-LM and post O-m recurrence rates were investigated and a Cox hazard test performed.
1 Davis MR et al. J Wom Health 2018; 27(10). Published online: https://doi.org/10.1089/jwh.2017.6752
2 Kotani Y et al. J Obstet Gynaecol Res 2018; 44(2): 298-302.
3 Glazer LM et al. Best Pract & Res Clin Obs & Gynaecol 2018; 46: 99-112
4 Stentz NC et al. Obste Gynecol 2017; 129:1007-13.

Almost 1 in 5 HCPs have used progesterone to treat UF

Which of the following medical treatments have you used for uterine fibroids?Which of the following medical treatments have you used for uterine fibroids?

Q7 pie

Q7 medical 1 Eder S et al. Women`s Health (London, England), 2013; 9(4):397-403.
2 Tosun AK et al. Pakistan J of Med Sciences, 2014 30(4): 834-839
3 Moroni RM et al. Gynecol Obstet Invest 2015; 79(3):145-52.
4 Donnez J. J Clin Med 2020; 9:3948.

X
  • TRANEXAMIC ACID – not licensed specifically for uterine fibroids
    • Licensed for treatment of cyclic heavy menstrual bleeding
    • Post-hoc analyses from two pivotal Phase 3 studies showed that TA significantly reduced the mean menstrual blood loss in women with fibroids1
    • Given during menses; oral with good safety/tolerability
  • LEVONORGESTREL (LNG) IUD – not licensed specifically for uterine fibroids
    • Licensed use includes treatment of heavy periods in women who choose intrauterine contraception
    • Significant reductions in Visual Bleeding Score shown in a small study comparing LNG-IUD (n=30) and oral progestin (n=30)1
    • Side effects include nausea and irregular bleeding
    • Cost a potential issue
  • COMBINED ORAL CONTRACEPTIVES – not all are fully licensed specifically for uterine fibroid
    • Non-contraceptive use includes symptomatic treatment of heavy menstrual bleeding
    • Database searched for all eligible uterine fibroid studies: only two found and evidence
      for use of COCs is very scarce, low quality and efficacy uncertain3

“Since progesterone is already implicated in the pathogenesis of [uterine fibroids], using
progestogens [alone] to manage fibroids is like constantly adding fuel to the fire, rendering this
treatment ineffective.” – Donnez J Journal of Clinical Medicine, 20204

  • A review of the most significant papers on the relationship between uterine fibroids and progesterone/progesterones, concludes that the evidence points to a lack of evidence of any efficacy1
  • GnRH AGONISTS
    • Monthly or quarterly injections
    • Duration limited due to side effects: significant bone mineral density loss, hot flushes, vaginal dryness2,3
  • SPRMs
    • Synthetic steroid ligands with a progesterone receptor target and tissue-selective effects of agonist and antagonist activities (ulipristal acetate)4
    • Recently identified cases of liver toxicity leading to liver failure; approved for use in EU and Canada but with restrictions
    • Use limited to short-term treatment before surgery
    • Longer-term treatment only in women with uterine fibroids not eligible for surgery

1 Eder S et al. Women`s Health (London, England), 2013; 9(4):397-403.
2 Tosun AK et al. Pakistan J of Med Sciences, 2014 30(4): 834-839
3 Moroni RM et al. Gynecol Obstet Invest 2015; 79(3):145-52.
4 Donnez J. J Clin Med 2020; 9:3948.

Awareness of new medical options?

Are you aware of a potential new class of treatments for uterine fibroids?Are you aware of a potential new class of treatments for uterine fibroids?

Q7 pie2

The survey is still open so if you haven’t been part of this important conversation, visit ufperspectives.com – because your perspective is important too

X

Awareness of new medical options?

Assuming safety was not an issue, what MINIMUM long-term efficacy* would a medical treatment need to demonstrate before you would prescribe it for symptomatic uterine fibroids?Assuming safety was not an issue, what MINIMUM long-term efficacy* would a medical treatment need to demonstrate before you would prescribe it for symptomatic uterine fibroids?

Q9-pie

The majority of HCPs would require a minimum efficacy of between 60-70%

The survey is still open so if you haven’t been part of this important conversation, visit ufperspectives.com – because your perspective is important too

X

“The anxiety that I feel every month thinking that my period is about to start.”

“Children, sleep, work, having to plan access to toilet prior to going out for a walk.”

“It’s a large fibroid and the pressure on my back gives me a nasty back pain that doesn’t allow long walks or runs or even a busy day of housework.”

“Can’t leave the house because of very heavy bleeding. I am in a lot of pain and take a lot of laxatives.”

“Just every day things like shopping and cleaning, messing about and playing with my children.”

“Heavy periods that last for up to six days a cycle.”

“Tired, mental and physical health, stained bedding, worrying about being out with no toilet access to change pads etc or the timings needed to access toilets, worrying about holiday planning, worrying when out if showing on clothing particularly when feeling a gush, no physical exercise to minimise accidents and slow flow, only wearing dark colours when having a period…..”

“I’m always tired because of anaemia that is cause of UF Unable to exercise, extreme painful periods Lack confidence because of weight gain.”

Awareness of new medical options?

If significant clinical outcomes were visible by the first menstruation following the start of treatment, would this be acceptable?If significant clinical outcomes were visible by the first menstruation following the start of treatment, would this be acceptable?

Q7 pie4Most HCPs would accept a new option if it demonstrated significant clinical outcomes by the first menstruation following treatment

The survey is still open so if you haven’t been part of this important conversation, visit ufperspectives.com – because your perspective is important too

X